Director, Clinical Pharmacology & Pharmacometrics
Pumas-AI, inc., France
Mélanie Wilbaux, PhD., Director, Clinical Pharmacology & Pharmacometrics at Pumas-AI, Inc.
Mélanie is a pharmacometrician, currently working as a consultant for Pumas-AI, since 2023, where she contributes her expertise in pharmacometrics to support drug development.
She has an extensive background in the application of mathematical and statistical models to evaluate and optimize the efficacy and safety of drugs. With 6 years of experience in the pharmaceutical industry, she acquired strong expertise in applying modeling & simulation approaches to inform drug development decisions, from first-in-human studies to regulatory submissions, in various disease areas.
Mélanie holds a PhD. in Pharmacometrics from the University of Lyon, France, (2014) where she focused on PK/PD modeling of tumor growth and biomarker kinetics to predict treatment efficacy. She did a post-doctoral fellowship at the University Children’s Hospital of Basel, Switzerland, dedicated on mathematical modeling in the pediatric population. She has also authored/co-authored several research publications in international peers' review journals and presented at various congresses.